Loading clinical trials...
Loading clinical trials...
Neuroprotection With Riluzole in Patients With Early Multiple Sclerosis
Conditions
Interventions
Avonex (Interferon beta 1a)
Riluzole
+1 more
Locations
1
United States
UCSF MS Center , 675 Nelson Rising Lane, Suite 221
San Francisco, California, United States
Start Date
July 1, 2006
Primary Completion Date
October 1, 2012
Completion Date
October 1, 2012
Last Updated
April 9, 2014
NCT06276634
NCT07225504
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions